Datasets:
tahasawan
/
Health_Dataset

Dataset card Data Studio Files
xet
 Community
2
Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
Japan
2,023
Dengue
Parasitic
7.28
2.75
8.98
61+
Male
230,036
72.44
4.13
5.54
Therapy
13,749
Yes
67.76
3,766
3.7
21,787
0.57
50.5
Nigeria
2,015
Hypertension
Viral
16
7.58
9.45
36-60
Male
943,177
69.97
1.18
1.99
Vaccination
12,713
Yes
73.64
465
2.67
27,661
0.8
34.88
India
2,013
Parkinson's Disease
Cardiovascular
9.45
8.26
5.19
61+
Other
37,439
91.4
0.62
5.61
Vaccination
35,565
Yes
91.47
374
3.71
3,399
0.41
49.09
Australia
2,016
Leprosy
Infectious
14.61
0.18
5.94
36-60
Other
280,996
99.5
4.91
3.78
Therapy
46,369
No
77.2
803
8.09
84,027
0.72
72.99
Australia
2,000
Zika
Neurological
11.27
13.78
6.65
36-60
Female
428,655
50.38
1.13
1.75
Vaccination
21,342
Yes
72.4
4,558
3.08
95,615
0.48
39.12
South Africa
2,015
Hypertension
Metabolic
16.04
2.13
8.09
0-18
Male
592,857
99.65
4.63
1.24
Surgery
19,889
Yes
60.91
1,137
1.25
95,748
0.7
45.6
Turkey
2,024
Zika
Respiratory
1.5
6.06
8.26
19-35
Male
667,292
91.86
4.26
4.6
Medication
35,889
Yes
70.32
1,491
5.48
5,130
0.41
58.63
China
2,003
Hepatitis
Respiratory
12.98
0.73
3.13
36-60
Other
992,012
65.93
0.81
2.69
Vaccination
4,004
No
94.48
4,938
5.42
65,189
0.78
69.55
USA
2,021
Rabies
Genetic
11
11.82
0.15
61+
Male
197,122
92.64
2.63
3.64
Surgery
47,468
No
73.51
1,779
2.35
69,253
0.63
87.01
Indonesia
2,000
Asthma
Infectious
13.59
5.16
2.49
61+
Other
513,904
79.33
4.62
3.26
Vaccination
44,436
Yes
57.88
186
7.12
66,195
0.57
75.63
South Africa
2,005
HIV/AIDS
Autoimmune
9.01
0.13
7.03
19-35
Other
234,348
96.07
4.81
1.31
Surgery
39,181
No
77.7
502
3.98
53,679
0.65
64.91
Indonesia
2,006
Asthma
Respiratory
17.97
5.88
4.49
0-18
Other
485,228
78.5
1.6
2.74
Vaccination
30,519
Yes
52.14
4,217
6.2
57,466
0.65
33.55
Brazil
2,000
Cancer
Bacterial
16.02
8.57
0.7
61+
Other
945,633
80.4
2.31
9.43
Medication
30,880
No
89.9
4,568
7.31
84,361
0.53
44.34
India
2,008
Polio
Cardiovascular
7.17
3.84
5.03
19-35
Female
645,018
86.03
2.51
3.21
Medication
19,018
No
57.35
1,601
4.26
59,182
0.48
59.32
Argentina
2,015
Measles
Bacterial
17.71
13.34
9.05
19-35
Other
28,171
76.71
2.75
7.2
Surgery
40,836
Yes
77.78
2,709
3.34
22,529
0.66
81.03
South Africa
2,011
Influenza
Neurological
10.67
9.05
8.47
0-18
Other
940,396
66.24
4.74
8.69
Medication
32,057
No
53.7
1,429
0.98
68,458
0.48
36.84
Canada
2,005
Asthma
Genetic
16.66
1.81
5.61
36-60
Female
11,985
86.41
1.05
6.01
Vaccination
9,606
Yes
81.81
2,222
8.11
76,425
0.46
36.95
South Africa
2,007
Ebola
Bacterial
17.18
8.98
4.01
36-60
Female
339,150
91.19
4.42
5.61
Medication
47,236
Yes
80.49
587
0.96
93,831
0.82
89.01
South Africa
2,008
Cholera
Cardiovascular
12
6.95
5.15
61+
Female
309,995
96.6
3.18
7.49
Vaccination
16,624
No
73.91
1,206
2.93
12,737
0.85
49.73
Japan
2,014
Zika
Bacterial
14.12
3.45
6.5
36-60
Other
85,481
53.04
4.09
7.5
Medication
31,249
No
50.44
1,462
4.09
82,851
0.58
76.19
China
2,003
Cancer
Infectious
1.95
5.72
7.92
61+
Male
187,249
93.57
0.79
3.09
Therapy
16,183
No
63.34
1,960
9.87
76,600
0.75
28.06
Nigeria
2,017
Hepatitis
Infectious
2.82
10.91
5.04
19-35
Female
353,839
79.83
2.93
6.16
Surgery
8,192
Yes
54.62
188
4.8
34,510
0.51
84.97
South Korea
2,001
Malaria
Neurological
9.29
7.34
5.94
36-60
Male
32,083
55.68
3.89
7.13
Medication
24,926
Yes
59.15
3,874
3.85
80,327
0.73
62.23
Japan
2,023
Zika
Chronic
20
12.67
2.03
36-60
Other
729,604
83.5
4.02
4.48
Surgery
18,212
No
55.39
700
8.31
75,702
0.83
71.54
South Korea
2,012
HIV/AIDS
Cardiovascular
4.39
2.76
6.87
19-35
Other
88,776
81.58
3.06
2.11
Medication
11,590
Yes
82.13
212
4.62
76,924
0.75
27.23
Russia
2,020
Cancer
Respiratory
10.72
3.24
4.78
0-18
Female
13,136
83.91
2.39
8.69
Vaccination
10,553
No
79.27
2,335
7.3
70,636
0.81
82.78
Argentina
2,014
Cholera
Viral
15.83
8.16
3.54
19-35
Female
953,937
80.51
2.24
7.74
Surgery
35,635
No
89.39
2,196
0.23
83,180
0.6
69.04
Argentina
2,014
Rabies
Metabolic
7.6
5.99
6.76
19-35
Female
491,998
97.68
3.21
7.82
Medication
14,263
Yes
65.32
151
5.68
3,742
0.62
74.4
USA
2,001
Cancer
Chronic
9.49
13.12
6.79
19-35
Male
239,331
93.58
2.22
9.89
Surgery
2,267
Yes
89.68
3,339
9.67
56,126
0.55
73.81
France
2,015
Alzheimer's Disease
Genetic
5.83
9.29
5.73
61+
Male
97,182
86.64
0.9
9.84
Medication
37,492
Yes
62.35
3,478
6.02
72,731
0.69
79.26
Brazil
2,022
Cholera
Metabolic
18.34
8.1
5.83
61+
Male
664,986
62.84
1.19
3.45
Medication
2,095
Yes
90.99
2,604
9.65
28,065
0.59
56.16
Canada
2,009
Cholera
Parasitic
0.74
1.45
7.24
19-35
Male
366,915
92.27
3.03
9.32
Medication
21,404
Yes
76.76
1,537
6.29
91,385
0.76
56.04
Canada
2,020
Parkinson's Disease
Viral
9.79
13.35
3.31
0-18
Male
747,433
73.93
1.89
7.88
Medication
6,813
Yes
70.29
1,734
2.66
9,935
0.85
23.17
Saudi Arabia
2,007
Rabies
Parasitic
8.3
0.42
5.3
61+
Male
319,739
93.69
4.48
1.66
Medication
13,337
No
68.11
4,144
8.27
94,821
0.83
60.32
Germany
2,009
Tuberculosis
Bacterial
15.58
9.5
7.79
61+
Female
179,661
88.61
0.84
4.76
Surgery
16,211
Yes
91.77
938
4.25
57,306
0.63
50.85
Indonesia
2,009
Polio
Cardiovascular
1.97
7.21
3.17
36-60
Male
639,875
56.64
4.37
6.64
Vaccination
41,565
Yes
65.2
2,534
6.6
44,547
0.7
68.88
Saudi Arabia
2,014
HIV/AIDS
Bacterial
18.1
2.43
4.38
0-18
Female
530,879
53.9
2.74
4.32
Medication
47,210
No
85.16
3,953
2.36
66,810
0.83
69.21
Japan
2,024
Dengue
Chronic
17.56
5.61
5.41
36-60
Female
422,664
93.3
4.88
9.36
Surgery
14,286
No
84.25
1,229
4.22
75,524
0.89
60.05
Russia
2,010
COVID-19
Viral
6.56
11.71
1.46
19-35
Female
442,535
65.6
4.88
5.82
Vaccination
8,289
Yes
50.49
3,201
3.06
31,122
0.76
51.65
Argentina
2,019
Alzheimer's Disease
Autoimmune
6.52
11.29
3.37
61+
Female
953,759
85.83
3.59
4.85
Medication
25,449
No
68.4
1,151
8.7
53,738
0.47
77.2
Canada
2,010
Polio
Metabolic
11.62
3.71
1.6
0-18
Female
321,880
79.77
4.14
9.83
Therapy
10,901
Yes
92.74
3,651
9.32
35,738
0.85
29.9
Argentina
2,003
Alzheimer's Disease
Autoimmune
15.87
0.67
6.15
0-18
Female
982,199
51.85
1.3
2.77
Therapy
24,787
No
75.19
3,904
1.79
20,368
0.89
87.69
Argentina
2,018
Parkinson's Disease
Viral
5.44
9.7
7.96
61+
Other
744,625
55.36
4.66
3.68
Therapy
48,209
Yes
53
2,539
0.46
7,952
0.88
28.02
Japan
2,003
Ebola
Chronic
11.2
2.05
3.67
19-35
Other
315,332
78.33
1.31
2.87
Therapy
7,542
No
71.5
3,228
2.29
51,953
0.52
27.31
Nigeria
2,023
Measles
Respiratory
4.48
4.96
8.83
19-35
Female
221,895
96.19
2.34
9.97
Surgery
47,160
Yes
79.48
2,969
9.69
6,193
0.81
20.6
Nigeria
2,007
Alzheimer's Disease
Respiratory
12.32
10.32
8.3
61+
Other
571,398
98.06
2.65
1.67
Therapy
26,847
No
75.76
4,221
4.6
52,339
0.83
31.22
Australia
2,006
Rabies
Autoimmune
19.47
3.59
7.33
36-60
Other
293,799
85.39
4.86
7.61
Therapy
40,544
Yes
89.5
2,736
7.44
44,190
0.65
30.03
USA
2,002
Rabies
Respiratory
3.34
6.99
0.93
0-18
Other
126,019
84.8
4.04
3.74
Surgery
44,861
No
62.39
4,361
6.87
4,155
0.42
60.69
Argentina
2,024
Dengue
Bacterial
9.74
11.01
8.24
61+
Other
988,472
96.78
3.97
9.46
Surgery
4,074
No
73.57
740
8.31
78,991
0.56
45.47
Argentina
2,010
Ebola
Genetic
12.8
4.04
6.93
19-35
Female
784,061
58.15
1.33
0.55
Vaccination
15,643
No
54.26
4,077
6.15
25,263
0.74
20.39
Brazil
2,007
Zika
Autoimmune
19.92
10.34
5.39
36-60
Male
302,924
96.32
2.59
8.44
Therapy
1,161
No
68.16
542
1.7
54,797
0.83
58.33
Mexico
2,020
HIV/AIDS
Bacterial
11.18
3.72
7.57
36-60
Female
963,932
61.45
4.28
3.82
Surgery
38,340
No
77.47
1,897
2.83
51,115
0.57
33.87
Indonesia
2,012
HIV/AIDS
Infectious
1.57
7.5
5.09
61+
Other
544,349
74.04
3.45
7.03
Medication
12,250
Yes
87.07
545
7.37
79,615
0.88
69.74
France
2,016
Dengue
Parasitic
5.84
5.43
5.4
61+
Other
159,524
68.16
2.42
0.55
Surgery
48,376
No
89.05
4,676
5.12
46,838
0.56
35.99
Australia
2,012
Parkinson's Disease
Autoimmune
2.44
8.61
6.94
61+
Other
996,563
75.55
2.6
2.24
Medication
49,176
No
51.61
2,137
4.1
20,696
0.49
74.2
USA
2,018
Malaria
Parasitic
16.09
3.24
8.94
0-18
Other
479,017
61.42
2.21
8.96
Surgery
13,947
Yes
69.35
673
9.57
15,297
0.85
69.76
Russia
2,005
Influenza
Autoimmune
9.75
2.56
8.47
61+
Other
179,326
90.35
3.5
1.84
Vaccination
39,432
No
74.89
4,430
0.65
94,864
0.82
60.65
Brazil
2,001
Asthma
Respiratory
19.27
3.55
6.11
0-18
Female
40,731
84.94
0.98
8.05
Vaccination
9,310
Yes
59.82
3,722
8.16
8,427
0.65
52.36
South Korea
2,012
Asthma
Neurological
2.28
14.11
9.42
0-18
Other
190,659
80.87
4.57
8.94
Surgery
174
No
86.7
660
4.26
17,740
0.52
41.44
Indonesia
2,021
Ebola
Respiratory
9.06
8.01
4.86
0-18
Male
63,486
72.5
3.24
1.94
Medication
27,354
Yes
73.07
3,062
0.36
89,364
0.45
34.74
Mexico
2,000
Parkinson's Disease
Bacterial
17.54
12.47
1.86
36-60
Female
181,924
84.63
1.54
5.91
Vaccination
48,629
No
72.11
2,413
1.05
49,828
0.67
47.81
Turkey
2,020
Parkinson's Disease
Infectious
0.36
4.36
5.99
61+
Male
450,804
60.51
2.37
3.4
Medication
42,032
No
91.51
4,691
4.91
34,790
0.79
28.89
Canada
2,007
Influenza
Parasitic
6.58
10.54
3.32
19-35
Female
342,411
99.92
2.46
6.2
Surgery
33,386
No
77.77
1,720
1.47
93,775
0.54
77.78
South Korea
2,013
Alzheimer's Disease
Autoimmune
3.17
5.45
3.4
19-35
Male
650,381
85.68
1.63
7.38
Surgery
45,935
Yes
65.89
177
5.46
26,490
0.44
54.62
South Africa
2,021
Cholera
Viral
17.83
9.44
9.88
19-35
Other
729,380
66.77
3.19
1.22
Therapy
18,138
No
53.29
4,680
6.29
12,438
0.42
29.54
Indonesia
2,009
COVID-19
Neurological
3.43
9.75
2.43
36-60
Other
817,987
85.47
4.57
3.22
Medication
44,585
Yes
78.87
4,366
9.54
35,376
0.53
57.38
Nigeria
2,001
Leprosy
Bacterial
18.31
12.3
3.46
19-35
Other
544,665
77.6
1.1
4.9
Surgery
29,544
No
70.12
2,838
0.17
16,621
0.55
31.07
Japan
2,013
HIV/AIDS
Neurological
7.54
14.43
7.38
61+
Male
337,401
56.1
3.67
2.75
Surgery
38,848
No
82.24
969
8.11
68,043
0.49
61.48
South Africa
2,011
Ebola
Viral
19.18
3.64
1.56
36-60
Male
391,922
67.56
1.92
1.54
Medication
39,358
Yes
91.47
4,035
1.32
45,450
0.46
31.12
Italy
2,006
Asthma
Respiratory
9.07
14.94
9.21
0-18
Other
970,996
74.99
5
3.63
Vaccination
34,270
Yes
80.29
884
2.2
45,929
0.88
83.04
UK
2,012
COVID-19
Neurological
16.77
10.88
4.84
61+
Other
593,509
73.08
2.08
3.08
Vaccination
19,883
Yes
55.49
1,233
1.69
78,243
0.52
40.21
Australia
2,014
Alzheimer's Disease
Chronic
10.62
1.15
8.05
0-18
Other
910,772
76.15
2.53
7.09
Vaccination
11,657
No
73.4
2,470
6.91
48,201
0.44
65.05
South Korea
2,002
Polio
Bacterial
6.15
2.96
5.12
19-35
Female
322,449
97.88
1.87
3.54
Therapy
6,719
No
60.08
1,098
6.25
78,212
0.64
32.18
Mexico
2,009
Parkinson's Disease
Metabolic
13.37
3.06
9.09
0-18
Male
277,697
98.86
2.88
1.44
Therapy
13,169
No
79.28
1,236
1.8
32,484
0.53
80.87
India
2,020
Parkinson's Disease
Metabolic
17.87
8.07
1.21
36-60
Female
732,806
63.4
1.7
3.26
Medication
7,682
No
90.27
1,719
8.49
787
0.45
30.66
Australia
2,024
Leprosy
Chronic
11.96
6.84
7.29
0-18
Female
419,800
98.45
0.61
4.6
Vaccination
1,545
Yes
95.06
3,437
1.76
96,857
0.72
73.93
China
2,020
Dengue
Infectious
19.84
1.97
4.41
36-60
Male
502,600
62.81
0.96
5.07
Surgery
9,317
Yes
52.22
3,461
7.69
70,091
0.71
66.31
USA
2,000
Leprosy
Cardiovascular
10.87
4.28
6.94
19-35
Male
359,015
76.64
1.11
5.78
Therapy
34,599
Yes
98
4,437
7.1
13,845
0.87
36.63
Turkey
2,005
Alzheimer's Disease
Viral
6.84
7.82
6.21
61+
Female
645,255
66.59
4.04
7.24
Vaccination
12,271
No
58.61
3,177
0.8
35,321
0.62
31.63
South Korea
2,012
COVID-19
Parasitic
4.14
1.04
6.78
0-18
Other
935,249
72.79
0.66
6.25
Vaccination
2,035
Yes
67.82
2,796
5.9
31,222
0.4
78.35
France
2,005
Hepatitis
Autoimmune
16.66
8.44
2.13
61+
Male
14,496
83.09
2.19
3.36
Therapy
31,715
Yes
81.13
1,599
3.76
68,543
0.84
71.35
USA
2,000
Diabetes
Neurological
9.89
3.4
3.37
0-18
Male
388,394
98.27
3.62
1.2
Vaccination
3,212
Yes
76.79
4,774
0.77
89,940
0.86
47.74
France
2,008
Parkinson's Disease
Genetic
12.61
0.71
2.96
61+
Male
21,250
59.71
1.93
5.98
Medication
408
No
63.35
253
0.73
7,230
0.43
24.67
Saudi Arabia
2,002
Malaria
Chronic
17.81
3.25
9.3
0-18
Other
391,961
78.9
2.61
2.53
Medication
13,272
Yes
91.95
2,353
9.2
61,765
0.48
22.33
France
2,018
Tuberculosis
Metabolic
7.68
12.46
9.23
36-60
Other
191,278
76.39
1.8
3.71
Surgery
35,752
Yes
92.18
323
8.34
57,149
0.51
48.44
USA
2,000
Dengue
Respiratory
18.62
14.76
9.68
19-35
Other
455,714
89.51
4.89
4.72
Vaccination
17,985
No
71.67
3,308
0.35
12,905
0.69
34.14
Argentina
2,006
Cholera
Neurological
0.65
0.39
7.97
19-35
Male
159,230
93.82
2.1
4.38
Vaccination
27,412
No
79.15
2,265
7.65
60,983
0.65
60.23
Russia
2,020
Alzheimer's Disease
Cardiovascular
12.45
9.64
1.25
19-35
Male
144,739
52.81
2.4
7.46
Vaccination
35,773
Yes
54.82
2,379
9.66
75,798
0.43
20.27
Argentina
2,006
Dengue
Parasitic
18.59
2.7
7
36-60
Female
539,904
91.71
1.61
4.06
Medication
10,407
No
67.81
570
0.57
91,108
0.9
32.31
India
2,001
Influenza
Bacterial
2.3
13.36
8.87
0-18
Other
739,652
94.53
1.75
7.59
Vaccination
42,318
No
60.1
4,011
5.66
90,170
0.89
30.04
Turkey
2,024
Rabies
Chronic
10.69
1.02
1.36
0-18
Male
435,225
55.7
1.48
2.89
Medication
3,390
Yes
71.52
3,653
9.28
10,060
0.46
63.13
Indonesia
2,018
Zika
Infectious
7.39
8.8
4.27
36-60
Female
694,439
96.35
0.6
1.63
Medication
25,184
No
83.26
1,826
9.99
59,685
0.6
28.92
South Africa
2,012
Measles
Chronic
9.6
8.92
1.25
61+
Other
844,728
87.7
3.97
4.98
Therapy
12,256
Yes
73.99
949
6.1
87,810
0.49
74.91
Mexico
2,024
Dengue
Bacterial
2.65
12.16
9.89
0-18
Other
862,642
60.03
1.03
1.79
Therapy
39,258
No
55.02
934
3.38
24,688
0.44
74.54
Russia
2,023
Polio
Autoimmune
11.15
10.1
5.82
61+
Male
143,680
77.42
4.4
2.47
Vaccination
21,526
Yes
54.48
4,999
2.23
88,927
0.86
48.28
Australia
2,005
Diabetes
Genetic
13.82
4.68
0.65
0-18
Other
508,290
77.36
4.16
3.05
Surgery
17,159
No
67.28
2,370
8.6
17,194
0.57
41.49
Germany
2,020
Cholera
Cardiovascular
11.8
8.79
7.67
61+
Other
134,438
80.56
2.45
7.6
Medication
22,795
Yes
97.08
759
9.41
45,540
0.71
89.56
Saudi Arabia
2,014
Hepatitis
Respiratory
5.92
13.43
3.19
36-60
Female
239,172
75.39
2.58
7.43
Vaccination
43,808
No
89.44
2,522
4.38
23,409
0.9
70.32
Turkey
2,014
Alzheimer's Disease
Infectious
6.17
8.73
7.74
61+
Female
137,583
96.55
2.1
3.56
Therapy
5,475
No
92.93
1,193
9.8
59,629
0.72
74.79
Saudi Arabia
2,022
Asthma
Chronic
17
3.19
7.51
36-60
Female
414,508
53.17
4.8
3.64
Medication
49,785
No
88.64
238
3.54
80,861
0.74
84.93